Many people with radiologically isolated syndrome (RIS) have hidden optic nerve changes found by special eye tests, but these changes alone do not predict who will develop MS symptoms.
In a study of 179 people with RIS, about 60% had silent optic nerve problems that did not cause noticeable vision symptoms. These hidden changes were found most often by visual evoked potentials (a test that measures how the brain responds to visual signals) and by OCT (a scan that measures the thickness of eye layers). Routine brain MRI missed most of these optic nerve findings, detecting them in only about 19% of cases. Adding optic nerve checks to the formal MS diagnostic rules made the criteria catch more people with abnormal tests, but it also labeled more people falsely as showing disease spread. The presence, side, or number of these silent optic nerve changes did not predict who later had a first clinical event (symptom) of MS during the study period.
People with RIS and their caregivers should know that special eye tests can find hidden optic nerve changes that routine scans often miss, like using a magnifying glass to see small cracks. Neurologists and eye doctors may use these extra tests to get a fuller picture, but finding a change doesn’t mean symptoms will happen soon. This matters for planning follow-up: someone with these changes might need closer monitoring or repeat tests, similar to checking a small leak more often even if it hasn’t caused damage yet. Caregivers can help by noting any subtle vision changes early and supporting regular testing when recommended. MS clinics may use a combination of tests (multimodal assessment) because each test finds different things, like using both a thermometer and a blood pressure cuff to understand overall health.
This study looked back at past records, so the people and testing were not all done the same way, which can affect results. The hidden optic nerve changes were common but did not predict who would develop symptoms, so finding them alone should not cause alarm. Because adding optic nerve tests to MS criteria can label more people as having spread of disease, doctors must interpret these results carefully to avoid unnecessary worry or treatment.
AI-generated summary — for informational purposes only, not medical advice
12/31/2026
Learn how certain gut bacteria can worsen MS symptoms and what this means for treatment and daily li
Read More7/1/2026
Study shows aerobic exercise alters brain circuits linked to automatic body control and fatigue in M
Read More7/1/2026
A simple eye scan and a blood test for sGFAP together help identify people with MS at higher risk of
Read More7/1/2026
MRI shows the choroid plexus is larger early in MS and links to inflammation and certain genes, sugg
Read More6/9/2026
Study finds miR-146a changes inflammation and lifespan in a motor neuron disease model, showing both
Read More6/2/2026
Severe eye movement trouble (INO) in MS can make quick visual thinking tests look worse. Tell your c
Read MoreWhether you’ve recently been diagnosed with Multiple Sclerosis (MS) or are seeking to broaden your understanding of this complex, neurodegenerative disease, navigating the latest research can feel overwhelming. Studies published in respected medical journals like Annals of clinical and translational neurology often range from early-stage, exploratory work to advanced clinical trials. These evidence-based findings help shape new disease-modifying therapies, guide symptom management techniques, and deepen our knowledge of MS progression.
However, not all research is created equal. Some clinical research studies may have smaller sample sizes, evolving methodologies, or limitations that warrant careful interpretation. For a more comprehensive, accurate understanding, we recommend reviewing the original source material—accessible via the More Details section above—and consulting with healthcare professionals who specialize in MS care.
By presenting a wide range of MS-focused studies—spanning cutting-edge treatments, emerging therapies, and established best practices—we aim to empower patients, caregivers, and clinicians to stay informed and make well-informed decisions when managing Multiple Sclerosis.